hVIVO plc is a United Kingdom-based purpose-built, full-service international clinical development partner and engaged in human challenge trials serving biopharma companies. The Company has an end-to-end platform designed to bring important medicines to patients faster: spanning preclinical strategy, first in human studies, Phase II patient trials and specialist laboratory services, delivered through a participant database, wholly owned sites and laboratories across the UK and Germany. The Company offers integrated service lines which include consulting, clinical trials, human challenge trials, and laboratories. Its consulting provides preclinical and clinical strategy, encompassing non-clinical, clinical, CMC, pharmacokinetics, data management, biostatistics, and regulatory support to guide trial design, execution, and interpretation. The Company is also focused on Phase I/II clinical studies, particularly in dermatology and women's health.
Back to dashboard
Company Information
About this company
Key people
Shaun Edward Chilton
Independent Non-Executive Chairman of the Board
Yamin Mohammed Khan
Chief Executive Officer, Executive Director
Stephen Pinkerton
Chief Financial Officer, Executive Director
Brendan Mary Buckley
Non-Executive Director
Richard John Cotton
Independent Non-Executive Director
Elaine Sullivan
Senior Independent Non-Executive Director
Click to see more
Key facts
- Shares in issue688.40m
- EPICHVO
- ISINGB00B9275X97
- LocationUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap£47.50m
- Employees376
- ExchangeLondon Stock Exchange (LON)
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.